B · Normal
On October 8, Huizhi agreed to acquire Pacira Biosciences for US$36.50 per share in cash, and the transaction is expected to be completed before the end of 2026.
Related telegraphs
[Very large oil tankers are rushing to the Middle East, further exacerbating the
10-08 14:39
[Reports say the U.S. military has been ordered to prepare for another attack on
10-08 09:43
On September 30, Hewlett Packard Enterprise (HPE) reached a US$1.2 billion deal
09-30 19:49
On September 29th, U.S. President Trump stated that a report just released by Ax
09-29 05:37
[Apple moves to restrict "Shake" ads] On September 23, a large number of iPhone
09-23 15:30
[Muse fire, Zuckerberg’s net worth soared by US$25 billion in one day] On Septem
09-22 15:39
Comments